SlideShare una empresa de Scribd logo
1 de 18
Descargar para leer sin conexión
Extravascular
     Administration
  Anas Bahnassi PhD RPh



One compartment Model
LECTURE’S OBJECTIVES
• Upon completion of this lecture, the student will able to:
• Calculate plasma drug concentration at any given time after the
  administration of an extravascular dose of a drug, based on known or
  estimated pharmacokinetic parameters
• Interpret the plasma drug concentration versus time curve of a drug
  administered extravascularly as the sum of an absorption curve and an
  elimination curve
• Employ extrapolation techniques to characterize the absorption phase
• Calculate the absorption rate constant and explain factors that influence
  this constant
• Explain possible reasons for the presence of lag time in a drug’s absorption
• Calculate peak plasma drug concentration, (Cp)max, and the time, (tmax)at
  which this occurs
• Explain the factors that influence peak plasma concentration and peak time
• Decide when flip-flop kinetics may be a factor in the plasma drug
  concentration versus time curve of a drug administered extravascularly.
                                                                         2
                          Anas Bahnassi PhD 2011
Xa                 Ka
                                     X
We Need the following info:
                                                                      Xu
1.   Equation for determining the plasma concentration at any time t.
2.   Determination of the elimination half life (t½) and rate constant (K or
     Kel).
3.   Determination of the absorption half life (t½)abs and absorption rate
     constant (Ka).
4.   Lag time (t0), if any.




                                                                                   Anas Bahnassi PhD 2011
5.   Determination of the apparent volume of distribution (V or Vd) and
     fraction of drug absorbed (F).
6.   Determination of the peak time (tmax).
7.   Determination of the peak plasma or serum concentration, (Cp)max.
                                                                               3
Graph
                        2.50
Concentration (ng/mL)




                        2.00



                        1.50



                        1.00




                                                                      Anas Bahnassi PhD 2011
                        0.50



                        0.00
                               0   4   8    12     16   20   24
                                                                  4
                                           Hours
Amount Remaining in the
  First         Administration Site
 Order
 Process
             ������������������
           −        = ������������ (������������ )������
              ������������
                             −������������ ������                  −������������ ������
(������������ )������ = (������������ )������=0 ������              = ������������������ ������
                      Bioavailability                  Dose
  100% Absorbed

                                            −������������ ������
                   (������������ )������ = ������������ ������
Monitoring Drug in Site of
           First                    Measurement
          Order
          Process
                          ������������������
                        −        = ������������ (������������ )������ − ������������
                           ������������
       ������������ (������������ )������=0 −������������
������������ =                  ������    − ������ −������������ ������
          ������������ − ������
       ������������ ������������0 −������������
������������ =            ������    − ������ −������������ ������
       ������������ − ������
Elimination Half life (t1/2)
And Elimination Rate Constant(k)
                             ������������ ������������0
                  ������������������ =               ������ −������������ − ������ −������������ ������
                           ������(������������ − ������)
          10.00




           1.00
            Concentration




                                               t½


           0.10
                            0   4   8    12    16     20     24
                                        Time
Calculating Absorption Rate
                                            Constant (ka)
 Method of Residuals

  Feathering Method
Time (h)         Observed Plasma Extrapolated Plasma                    (������������)������������������������ = ������������������������������ − ������������������������������
                 Concentrations  Concentrations
                 (Cp)observed    (Cp)extrapolated
Time values      Values only from the        Values only from the      Differences between
corresponding    absorption phase            extrapolated portion of   extrapolated and observed
to observed      (i.e. all values prior to   the plot of plasma        values for each time in the
plasma           reaching maximum            concentration–time        absorption phase (units,
concentrations   or highest plasma           (units, e.g. (mgmL1)      e.g. mgmL-1)
for absorption   concentration) (units,
phase only       e.g. mgmL-1)



                                        ������������ ������������0
                     ������������������������������������   =               ������ −������������ ������
                                      ������(������������ − ������)
                                                                                                       8
                                                                                    Anas Bahnassi PhD 2011
Calculating Absorption Rate
                              Constant (ka)
Method of Residuals

Feathering Method




                                                ������������
                                   Slope=−
                                               2.303




                      Anas Bahnassi PhD 2011           9
Lag Time (t0)
Theoretically, intercepts of the terminal linear portion
and the feathered line should be the same; however,
sometimes, these two lines do not have the same
intercepts, Sometimes absorption starts after
administration, this delay may be contributed to:

  •    Slow tablet disintegration
  •    Slow and/or poor dissolution
  •    Incomplete wetting of drug particles
  •    Poor formula
  •    Delayed Release formula



                     Anas Bahnassi PhD 2011                10
Negative Lag Time (t0)
The presence of a negative lag time may be attributed to
inadequate data points in the absorption phase as well
as in the elimination phase. Another possible reason
may be that the absorption rate constant is not much
greater than the elimination rate constant.




                 Anas Bahnassi PhD 2011                    11
Analysis of Absorption
       ������������ ≫ ������         Rate Constant

 Quicker     Faster Onset   ������������ for a given drug can
Absorption     of Action    change as a result of:

                            • Changing the formulation
                            • Changing the dosage form
                              or the extravascular route
                              of administration.
                            • Administration of a drug
                              with or without food.
Apparent Volume of
Cannot be calculated from plasma   Distribution(Vd)
drug concentration data alone
WHY?
The fraction of drug absorbed (F) is
not known.
If the drug is 100 percent
absorbed; F=1 then
                        ������������ ������������0
 ������������������������������������������������������ =               If F is not known then it is best to
                      ������(������������ − ������)
                                                ������
                                    calculate
                                                   ������
                                        ������   ������������ ������0         1
                                           =          (                  )
                                        ������ (������������ −������) ������������������������������������������������������


                        Anas Bahnassi PhD 2011                               13
Calculating Peak Time(tmax)
������������
     = ������������ ������������ − ������������                  When t=tmax ������������ ������������ = ������������
������������
������������
     = ������������ (������������ )������������������������ − ������(������)������������������������ = 0
������������

   ������������ (������������ )������������������������ = ������(������)������������������������
           ������������ ������������0 −������������
 ������������ =                  ������   − ������ −������������ ������
          ������������ − ������
                 ������������ ������������0 −������������
������������������������������ =                ������ ������������������ − ������ −������������ ������������������������    ������������ ������        = ������������ −������������ ������������������������
                ������������ − ������                                          ������������������




                                    Anas Bahnassi PhD 2011                                      14
Calculating Peak Time(tmax)


Taking natural log of both sides:




              Anas Bahnassi PhD 2011   15
Significance of Peak Time(tmax)
•   To determine comparative bioavailability and/or
    bioequivalence
•   To determine the preferred route of drug administration and
    the desired dosage form for the patient
•   To assess the onset of action.

                                      Significance of Peak
                                      Concentration(Cmax)
• Used to determine the comparative bioavailability and/or the
  bioequivalence between two products.
• Used to determine the superiority between two different
  dosage forms or two different routes of administration
• Correlates with the pharmacological effect of a drug.
                     Anas Bahnassi PhD 2011                 16
Plot the data and, using the plot, determine


Question
                         the following.
                         a. The elimination half life (t1/2) for each dose.
                         b. The elimination rate constant (K) for each
                         dose.
                         c. The absorption half life, (t1/2)abs, for each
                         dose.
                         d. The absorption rate constant (Ka) for each
                         dose.
                         e. The observed and computed peak time (tmax)
                         for each dose.
                         f. The observed and computed peak plasma
                         concentrations, (Cp)max, for each dose.
                         g. The y-axis intercept for each dose.
                         h. The apparent volume of distribution (V).
                         i. The fraction of drug absorbed (F).
                         j. The characteristics of a plot on rectilinear
                         paper of peak time (tmax) against the
                         administered dose (then make an important
                         observation).
                         k. The characteristics of a plot on rectilinear
                         paper of peak plasma concentrations, (Cp)max,
                         i. Lag time if any.
                                                                 17
Anas Bahnassi PhD 2011
Pharmacokinetics

Anas Bahnassi PhD RPh

                           abahnassi@gmail.com

                      http://twitter.com/abahnassi

            http://www.linkedin.com/in/abahnassi

        http://www.udemy.com/pharmacokinetics

             http://www.slideshare.net/abahnassi

        attribution – non-commercial – share alike

Más contenido relacionado

La actualidad más candente

one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model pptSheetal Jha
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing BioavailabilityDibrugarh University
 
Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsSnehal Patel
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionAreej Abu Hanieh
 
Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studiesSonam Gandhi
 
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)DR. METI.BHARATH KUMAR
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationMalla Reddy College of Pharmacy
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Sulekha Rohilla
 
One compartment model intro
One compartment model introOne compartment model intro
One compartment model introPankaj Nerkar
 
One compartment-open-model
One compartment-open-modelOne compartment-open-model
One compartment-open-modelRana Ahmed
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment ModellingPallavi Kurra
 
Non linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionNon linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionMalla Reddy College of Pharmacy
 
IN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONIN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONN Anusha
 
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTIONBIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTIONKrutika Pardeshi
 

La actualidad más candente (20)

one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model ppt
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
 
Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokinetics
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorption
 
Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studies
 
Multiple Dosage regimen
Multiple Dosage regimenMultiple Dosage regimen
Multiple Dosage regimen
 
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1
 
One compartment model intro
One compartment model introOne compartment model intro
One compartment model intro
 
One compartment-open-model
One compartment-open-modelOne compartment-open-model
One compartment-open-model
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment Modelling
 
Bioavailability Studies
Bioavailability StudiesBioavailability Studies
Bioavailability Studies
 
Drug distribution & clearance
Drug distribution & clearanceDrug distribution & clearance
Drug distribution & clearance
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Non linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionNon linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distribution
 
IN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONIN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATION
 
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTIONBIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
 
Pharmacokinetics of drug absorption
Pharmacokinetics of drug absorptionPharmacokinetics of drug absorption
Pharmacokinetics of drug absorption
 

Similar a Pharmacokinetics: Lecture four

Aaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya Udupa
 
Pharmacokinetics
Pharmacokinetics Pharmacokinetics
Pharmacokinetics Umesh Yadav
 
Session 2 part 2
Session 2 part 2Session 2 part 2
Session 2 part 2plmiami
 
Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelDetermination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelAbhinayJha3
 
Determination of absorption and elimination rates on base of compartment model
 Determination of absorption and elimination rates on base of compartment model Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelAbhinayJha3
 

Similar a Pharmacokinetics: Lecture four (8)

Pharmacokinetics: Lecture two
Pharmacokinetics: Lecture twoPharmacokinetics: Lecture two
Pharmacokinetics: Lecture two
 
Aaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya- calculation of pk parameters
Aaditya- calculation of pk parameters
 
Pharmacokinetics
Pharmacokinetics Pharmacokinetics
Pharmacokinetics
 
Pharmacokinetics of Oral Drug Absorption
Pharmacokinetics of Oral Drug AbsorptionPharmacokinetics of Oral Drug Absorption
Pharmacokinetics of Oral Drug Absorption
 
Session 2 part 2
Session 2 part 2Session 2 part 2
Session 2 part 2
 
Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelDetermination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
 
Determination of absorption and elimination rates on base of compartment model
 Determination of absorption and elimination rates on base of compartment model Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
 
Onecompartmentmodeling
OnecompartmentmodelingOnecompartmentmodeling
Onecompartmentmodeling
 

Más de Anas Bahnassi أنس البهنسي

Pharmacy Practice: Lecture one: Medication Management Cycle Part One
Pharmacy Practice: Lecture one: Medication Management Cycle Part OnePharmacy Practice: Lecture one: Medication Management Cycle Part One
Pharmacy Practice: Lecture one: Medication Management Cycle Part OneAnas Bahnassi أنس البهنسي
 

Más de Anas Bahnassi أنس البهنسي (20)

Lecture nine cardiovascular_emeregencies
Lecture nine cardiovascular_emeregenciesLecture nine cardiovascular_emeregencies
Lecture nine cardiovascular_emeregencies
 
Urinary Tract Infections
Urinary Tract InfectionsUrinary Tract Infections
Urinary Tract Infections
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Influenza
InfluenzaInfluenza
Influenza
 
Acute bronchitis
Acute bronchitisAcute bronchitis
Acute bronchitis
 
Sinusitis
SinusitisSinusitis
Sinusitis
 
Streptococccal sore throat
Streptococccal sore throatStreptococccal sore throat
Streptococccal sore throat
 
Acute Otitis Media
Acute Otitis Media Acute Otitis Media
Acute Otitis Media
 
Principles of infectious diseases
Principles of infectious diseasesPrinciples of infectious diseases
Principles of infectious diseases
 
Lecture three management cycle Part 3
Lecture three management cycle Part 3Lecture three management cycle Part 3
Lecture three management cycle Part 3
 
Lecture two management cycle Part: 2
Lecture two management cycle Part: 2Lecture two management cycle Part: 2
Lecture two management cycle Part: 2
 
Pharmacy Practice: Lecture one: Medication Management Cycle Part One
Pharmacy Practice: Lecture one: Medication Management Cycle Part OnePharmacy Practice: Lecture one: Medication Management Cycle Part One
Pharmacy Practice: Lecture one: Medication Management Cycle Part One
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Juvenile idiopathic arthritis
Juvenile idiopathic arthritisJuvenile idiopathic arthritis
Juvenile idiopathic arthritis
 
Rheumatoid arthritis Part 2
Rheumatoid arthritis Part 2Rheumatoid arthritis Part 2
Rheumatoid arthritis Part 2
 
Rheumatoid Arthritis Part !
Rheumatoid Arthritis Part !Rheumatoid Arthritis Part !
Rheumatoid Arthritis Part !
 
Pharmacotherapy of Diabetes: Part 2
Pharmacotherapy of Diabetes: Part 2Pharmacotherapy of Diabetes: Part 2
Pharmacotherapy of Diabetes: Part 2
 
Role of community pharmacists in diabetes management
Role of community pharmacists in diabetes managementRole of community pharmacists in diabetes management
Role of community pharmacists in diabetes management
 
Diabetes Care: Part One
Diabetes Care: Part OneDiabetes Care: Part One
Diabetes Care: Part One
 
Premixed insulin dosing in actual practice
Premixed insulin dosing in actual practicePremixed insulin dosing in actual practice
Premixed insulin dosing in actual practice
 

Último

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 

Último (20)

Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 

Pharmacokinetics: Lecture four

  • 1. Extravascular Administration Anas Bahnassi PhD RPh One compartment Model
  • 2. LECTURE’S OBJECTIVES • Upon completion of this lecture, the student will able to: • Calculate plasma drug concentration at any given time after the administration of an extravascular dose of a drug, based on known or estimated pharmacokinetic parameters • Interpret the plasma drug concentration versus time curve of a drug administered extravascularly as the sum of an absorption curve and an elimination curve • Employ extrapolation techniques to characterize the absorption phase • Calculate the absorption rate constant and explain factors that influence this constant • Explain possible reasons for the presence of lag time in a drug’s absorption • Calculate peak plasma drug concentration, (Cp)max, and the time, (tmax)at which this occurs • Explain the factors that influence peak plasma concentration and peak time • Decide when flip-flop kinetics may be a factor in the plasma drug concentration versus time curve of a drug administered extravascularly. 2 Anas Bahnassi PhD 2011
  • 3. Xa Ka X We Need the following info: Xu 1. Equation for determining the plasma concentration at any time t. 2. Determination of the elimination half life (t½) and rate constant (K or Kel). 3. Determination of the absorption half life (t½)abs and absorption rate constant (Ka). 4. Lag time (t0), if any. Anas Bahnassi PhD 2011 5. Determination of the apparent volume of distribution (V or Vd) and fraction of drug absorbed (F). 6. Determination of the peak time (tmax). 7. Determination of the peak plasma or serum concentration, (Cp)max. 3
  • 4. Graph 2.50 Concentration (ng/mL) 2.00 1.50 1.00 Anas Bahnassi PhD 2011 0.50 0.00 0 4 8 12 16 20 24 4 Hours
  • 5. Amount Remaining in the First Administration Site Order Process ������������������ − = ������������ (������������ )������ ������������ −������������ ������ −������������ ������ (������������ )������ = (������������ )������=0 ������ = ������������������ ������ Bioavailability Dose 100% Absorbed −������������ ������ (������������ )������ = ������������ ������
  • 6. Monitoring Drug in Site of First Measurement Order Process ������������������ − = ������������ (������������ )������ − ������������ ������������ ������������ (������������ )������=0 −������������ ������������ = ������ − ������ −������������ ������ ������������ − ������ ������������ ������������0 −������������ ������������ = ������ − ������ −������������ ������ ������������ − ������
  • 7. Elimination Half life (t1/2) And Elimination Rate Constant(k) ������������ ������������0 ������������������ = ������ −������������ − ������ −������������ ������ ������(������������ − ������) 10.00 1.00 Concentration t½ 0.10 0 4 8 12 16 20 24 Time
  • 8. Calculating Absorption Rate Constant (ka) Method of Residuals Feathering Method Time (h) Observed Plasma Extrapolated Plasma (������������)������������������������ = ������������������������������ − ������������������������������ Concentrations Concentrations (Cp)observed (Cp)extrapolated Time values Values only from the Values only from the Differences between corresponding absorption phase extrapolated portion of extrapolated and observed to observed (i.e. all values prior to the plot of plasma values for each time in the plasma reaching maximum concentration–time absorption phase (units, concentrations or highest plasma (units, e.g. (mgmL1) e.g. mgmL-1) for absorption concentration) (units, phase only e.g. mgmL-1) ������������ ������������0 ������������������������������������ = ������ −������������ ������ ������(������������ − ������) 8 Anas Bahnassi PhD 2011
  • 9. Calculating Absorption Rate Constant (ka) Method of Residuals Feathering Method ������������ Slope=− 2.303 Anas Bahnassi PhD 2011 9
  • 10. Lag Time (t0) Theoretically, intercepts of the terminal linear portion and the feathered line should be the same; however, sometimes, these two lines do not have the same intercepts, Sometimes absorption starts after administration, this delay may be contributed to: • Slow tablet disintegration • Slow and/or poor dissolution • Incomplete wetting of drug particles • Poor formula • Delayed Release formula Anas Bahnassi PhD 2011 10
  • 11. Negative Lag Time (t0) The presence of a negative lag time may be attributed to inadequate data points in the absorption phase as well as in the elimination phase. Another possible reason may be that the absorption rate constant is not much greater than the elimination rate constant. Anas Bahnassi PhD 2011 11
  • 12. Analysis of Absorption ������������ ≫ ������ Rate Constant Quicker Faster Onset ������������ for a given drug can Absorption of Action change as a result of: • Changing the formulation • Changing the dosage form or the extravascular route of administration. • Administration of a drug with or without food.
  • 13. Apparent Volume of Cannot be calculated from plasma Distribution(Vd) drug concentration data alone WHY? The fraction of drug absorbed (F) is not known. If the drug is 100 percent absorbed; F=1 then ������������ ������������0 ������������������������������������������������������ = If F is not known then it is best to ������(������������ − ������) ������ calculate ������ ������ ������������ ������0 1 = ( ) ������ (������������ −������) ������������������������������������������������������ Anas Bahnassi PhD 2011 13
  • 14. Calculating Peak Time(tmax) ������������ = ������������ ������������ − ������������ When t=tmax ������������ ������������ = ������������ ������������ ������������ = ������������ (������������ )������������������������ − ������(������)������������������������ = 0 ������������ ������������ (������������ )������������������������ = ������(������)������������������������ ������������ ������������0 −������������ ������������ = ������ − ������ −������������ ������ ������������ − ������ ������������ ������������0 −������������ ������������������������������ = ������ ������������������ − ������ −������������ ������������������������ ������������ ������ = ������������ −������������ ������������������������ ������������ − ������ ������������������ Anas Bahnassi PhD 2011 14
  • 15. Calculating Peak Time(tmax) Taking natural log of both sides: Anas Bahnassi PhD 2011 15
  • 16. Significance of Peak Time(tmax) • To determine comparative bioavailability and/or bioequivalence • To determine the preferred route of drug administration and the desired dosage form for the patient • To assess the onset of action. Significance of Peak Concentration(Cmax) • Used to determine the comparative bioavailability and/or the bioequivalence between two products. • Used to determine the superiority between two different dosage forms or two different routes of administration • Correlates with the pharmacological effect of a drug. Anas Bahnassi PhD 2011 16
  • 17. Plot the data and, using the plot, determine Question the following. a. The elimination half life (t1/2) for each dose. b. The elimination rate constant (K) for each dose. c. The absorption half life, (t1/2)abs, for each dose. d. The absorption rate constant (Ka) for each dose. e. The observed and computed peak time (tmax) for each dose. f. The observed and computed peak plasma concentrations, (Cp)max, for each dose. g. The y-axis intercept for each dose. h. The apparent volume of distribution (V). i. The fraction of drug absorbed (F). j. The characteristics of a plot on rectilinear paper of peak time (tmax) against the administered dose (then make an important observation). k. The characteristics of a plot on rectilinear paper of peak plasma concentrations, (Cp)max, i. Lag time if any. 17 Anas Bahnassi PhD 2011
  • 18. Pharmacokinetics Anas Bahnassi PhD RPh abahnassi@gmail.com http://twitter.com/abahnassi http://www.linkedin.com/in/abahnassi http://www.udemy.com/pharmacokinetics http://www.slideshare.net/abahnassi attribution – non-commercial – share alike